Squarepoint’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,928
Closed -$79.4K 4270
2025
Q4
$79.4K Buy
+26,928
New +$73.7K ﹤0.01% 4075
2025
Q3
Sell
-17,888
Closed -$58.7K 4359
2025
Q2
$58.7K Sell
17,888
-35,760
-67% -$130K ﹤0.01% 4283
2025
Q1
$207K Buy
53,648
+11,058
+26% +$45.9K ﹤0.01% 3997
2024
Q4
$164K Buy
+42,590
New +$235K ﹤0.01% 4545
2023
Q3
Sell
-116,391
Closed -$1.36M 3777
2023
Q2
$1.36M Buy
116,391
+11,000
+10% +$104K ﹤0.01% 1939
2023
Q1
$812K Buy
105,391
+59,942
+132% +$486K ﹤0.01% 2021
2022
Q4
$418K Buy
+45,449
New +$506K ﹤0.01% 2381

Other funds holding BAK

Squarepoint's BAK Position: Q1 2026 in Review

Squarepoint sold out of Braskem (BAK) in Q1 2026, closing a stake of 26,928 shares — an estimated $79.4K sold.

Squarepoint first reported a position in BAK in Q4 2022 and held it in 7 quarters. The position peaked at $1.36M in Q2 2023. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • Squarepoint reported no remaining Braskem position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 26,928 Braskem shares in Q1 2026, an estimated $79.4K.
  • Squarepoint first reported a position in Braskem in Q4 2022 and held it in 7 quarters.
  • Squarepoint's Braskem position peaked at $1.36M in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.